vTv Therapeutics, Inc.
(NASDAQ : VTVT)

( )
VTVT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -3.94%74.671.0%$1808.50m
AMGNAmgen, Inc. -1.32%208.781.3%$898.33m
REGNRegeneron Pharmaceuticals, Inc. -0.55%501.512.6%$832.58m
BIIBBiogen, Inc. -3.27%301.211.5%$768.55m
VRTXVertex Pharmaceuticals, Inc. -2.99%247.671.9%$644.24m
MRNAModerna, Inc. -7.56%32.020.0%$518.77m
ILMNIllumina, Inc. 0.95%280.643.5%$494.32m
ALXNAlexion Pharmaceuticals, Inc. -1.24%94.722.0%$299.75m
AAgilent Technologies, Inc. -0.46%74.021.6%$226.92m
INCYIncyte Corp. 1.82%86.662.5%$218.22m
EXASEXACT Sciences Corp. 0.53%62.6021.0%$178.66m
SGENSeattle Genetics, Inc. -2.09%121.876.1%$164.60m
BMRNBioMarin Pharmaceutical, Inc. -3.55%79.834.3%$153.92m
IMMUImmunomedics, Inc. 0.69%18.9111.9%$120.80m
NVAXNovavax, Inc. -7.45%14.90114.7%$113.95m

Company Profile

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.